• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CARDINAL HEALTH MEXICO RX/5MM BASKET DIAMETER/180CM; TEMPORARY CAROTID CATHETER FOR EMBOLIC CAPTURE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CARDINAL HEALTH MEXICO RX/5MM BASKET DIAMETER/180CM; TEMPORARY CAROTID CATHETER FOR EMBOLIC CAPTURE Back to Search Results
Catalog Number 501814RE
Device Problems Stretched (1601); Unraveled Material (1664)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/01/2020
Event Type  malfunction  
Manufacturer Narrative
The device has been returned for evaluation, but the manufacture report is not yet available.A review of the device history record (dhr) associated with lot 35261340 revealed no anomalies during the manufacturing and inspection processes that can be associated with the reported event.Additional information is pending and will be sent in upon 30 days after receipt.
 
Event Description
As reported, a 5mm x 180cm angioguard rapid exchange (rx) guidewire system was used; however, during the process of inserting the device, it could not be released when it reached the lesion.Therefore, the device was withdrawn.The product analysis shows a 18cm of length unzipped condition was observed on the delivery sheath located at 31 cm from the distal end, and a 40cm of length unzipped condition was observed on the delivery sheath located at 140 cm from the distal end.There was no reported patient injury.Angiography found a chronic occlusion of the carotid artery followed by carotid artery stent implantation.The device was stored for two weeks.The device was stored, handled and prepped per the instructions per use (ifu).The angioguard was sized larger than the vessel as instructed in the ifu.There was no difficulty experienced when removing the catheter from its packaging.There was no unusual force used at anytime during the procedure.The device did not pass through any acute bends.There was no difficulty encountered while advancing/tracking the device towards the lesion.Sufficient space was allowed between the lesion and the filter basket to prevent interaction between devices.There was no difficulty or resistance noted while crossing the lesion with the device.The target lesion was the proximal tip of the internal carotid artery.The lesion was not calcified.There was no vessel tortuosity.There was seventy percent stenosis.The device was not used for a chronic total occlusion.The procedure was completed using another angioguard.The device will be returned for evaluation.
 
Manufacturer Narrative
The device has been returned for evaluation, but the manufacture report is not yet available.Due to systems limitation the report was created in error.Additional information is pending and will be sent in upon 30 days after receipt.
 
Manufacturer Narrative
A angioguard 5mm x 180cm rapid exchange (rx) guidewire system was used; however, during the process of inserting the device, it could not be released when it reached the lesion.Therefore, the device was withdrawn.The product analysis shows a 18cm of length unzipped condition was observed on the delivery sheath located at 31 cm from the distal end, and a 40cm of length unzipped condition was observed on the delivery sheath located at 140 cm from the distal end.Angiography found a chronic occlusion of the carotid artery followed by carotid artery stent implantation.The device was stored for two weeks.The device was stored, handled and prepped per the instructions per use (ifu).The angioguard was sized larger than the vessel as instructed in the ifu.There was no difficulty experienced when removing the catheter from its packaging.There was no unusual force used at any time during the procedure.The device did not pass through any acute bends.There was no difficulty encountered while advancing/tracking the device towards the lesion.Sufficient space was allowed between the lesion and the filter basket to prevent interaction between devices.There was no difficulty or resistance noted while crossing the lesion with the device.The target lesion was the proximal tip of the internal carotid artery.The lesion was not calcified.There was no vessel tortuosity.There was seventy percent stenosis.The device was not used for a chronic total occlusion.The procedure was completed using another angioguard.There was no reported patient injury.The device was returned for analysis.A non-sterile unit of a product ¿rx/5mm basket diameter/180cm¿ was received inside of a clear plastic bag.Device was unpacked in order to perform the visual evaluation.The returned component was the ecgw system.The rest of the components were not returned.The filter basket was found over captured in the delivery sheath.In addition, two unzipped areas were observed at the delivery sheath: a 18 cm of length unzipped condition was observed on the delivery sheath located at 31 cm from the distal end, and a 40 cm of length unzipped condition was observed on the delivery sheath located at 140 cm from the distal end.No damages or anomalies were observed on the returned product.Functional analysis could not be properly performed due to the filter basket is over captured in the delivery sheath.A product history record (phr) review of lot 35261340 revealed no anomalies or non-conformances during the manufacturing and inspection processes that can be associated with the reported event.The reported ¿delivery system- deployment difficulty ¿ unable was confirmed since the device was received over captured.The reported ¿distal tip- unraveled/stretched was confirmed since the tip was found unraveled.However, two unzipped areas were noted at the delivery sheath: a 18 cm of length unzipped condition was observed on the delivery sheath located at 31 cm from the distal end, and a 40 cm of length unzipped condition was observed on the delivery sheath located at 140 cm from the distal end.The exact cause of the observed condition could not be conclusive determined during the analysis.It is difficult to draw a clinical conclusion between the device and the events based on the information available.However, it is probable that procedural and or handling factors such as the user¿s interaction with the device and vessel characteristics (seventy percent stenosis) may have led to the reported events.According to the instructions for use (ifu) ¿gripping the torque device in one hand and the coil dispenser in the other, pull on the wire until the basket is completely docked into the tip of the deployment sheath.When completely docked, approximately half the filter basket will still be visible out the end of the deployment sheath.¿ additionally, ¿separate the deployment sheath hub from the guidewire by grasping the guidewire proximally in one hand and pulling the hub away from the wire with the thumb and index finger of the other hand.While maintaining the guidewire position, use the hub to peel the deployment sheath up to the hemovalve.Place one hand over the hemovalve and grasp it with the ring and little fingers.Open the hemovalve.Maintain guidewire position by holding the guidewire between the thumb and index finger of the same hand.With the other hand, peel the deployment sheath from the guidewire by pulling on the hub parallel to the axis of the guidewire.Complete the peeling step by pulling on the black deployment sheath.Peeling is complete within a few centimeters of the black to yellow sheath color change.Remove the remaining un-slit sheath using a standard over-the-wire technique.¿ neither the phr review nor the product analysis suggests that the reported events could be related to the manufacturing process of the unit.Therefore, no corrective or preventive actions will be taken.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RX/5MM BASKET DIAMETER/180CM
Type of Device
TEMPORARY CAROTID CATHETER FOR EMBOLIC CAPTURE
Manufacturer (Section D)
CARDINAL HEALTH MEXICO
av prado sur 150 2d0 piso
ciudad de mexico 11000
MX  11000
MDR Report Key11307096
MDR Text Key233591187
Report Number9616099-2021-04254
Device Sequence Number1
Product Code NTE
Combination Product (y/n)N
PMA/PMN Number
K062531
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup,Followup
Report Date 03/31/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/10/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/28/2022
Device Catalogue Number501814RE
Device Lot Number35261340
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/21/2020
Date Manufacturer Received03/29/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
UNK STENT
Patient Age69 YR
Patient Weight83
-
-